A full range of UK and European stocks
Markets participants, including retail investors and institutions, can trade UK Stocks listed on the Main Market or admitted to trading on AIM.
London Stock Exchange’s Main Market is the world’s most internationally connected platform for the admission and trading of equity, debt and other securities. AIM was launched in 1995 and has since become is the world’s most successful growth market.
As well as all Securities directly admitted by London Stock Exchange (Main Market, AIM, Professional Securities Market, International Securities Market and Admission to Trading only) London Stock Exchange also provides the following equity and equity-like securities admitted by other EEA Regulated Markets and MTFs for On Exchange trade reporting:
- Those deemed liquid by ESMA are on the European Quoting service (EQS)
- Those deemed NOT liquid by ESMA are SSX4 SXEL of SETSqx
Explore
Find out about companies we have welcomed to our markets
London Stock Exchange welcomes J.P. Morgan Asset Management to celebrate its new sustainable ETF
Today the London Stock Exchange markets were opened by J.P. Morgan Asset Management (JPMAM) to celebrate the launch of JPMorgan Carbon Transition Global Equity UCITS ETF (ticker: JPCT), a sustainable ETF which offers core exposure to global equities with a low tracking error, compared to the MSCI World Index, and have a meaningful reduction in carbon intensity.
JPCT will track the JPM
London Stock Exchange welcomes Barclays Celebrating its Green Bond issuance
Sasha Wiggins, Group Head of Public Policy and Corporate Responsibility at Barclays this morning opened the market at London Stock Exchange in recognition of the listing of the bank’s second Green Bond. The bond was listed on Tuesday 3 November, raising £400m to support the development of Barclays’ Green Mortgages portfolio.
Commenting on the Green Bond issuance Sasha Wiggins, Group H
London Stock Exchange Welcomes Verici Dx plc to AIM
London Stock Exchange welcomes Verici Dx plc (‘Verici Dx’ or the ‘Company’), a developer of advanced clinical diagnostics for organ transplant, to celebrate the listing of the Company's public shares onto AIM, under the ticker "VRCI".
Verici Dx is an immuno-diagnostics development company, initially focused on the kidney transplantation market. The Company's kidney transplant
London Stock Exchange welcomes SourceBio International plc to AIM
London Stock Exchange today welcomes SourceBio International plc (‘SourceBio’ or the ‘Company’), a leading international provider of integrated state-of-the-art laboratory services and products, to celebrate the listing of the Company's public shares onto AIM, under the ticker "SBI".
SourceBio, employs approximately 235 employees across six sites globally, in the UK, Ireland and the U